In the RVO with macular ischemia, macular ischemia decreased significantly after anti-VEGF treatment, especially in the superficial retinal layer, and the VD and macular ISI in the deep plexus remained stable without exacerbation of ischemia. This evidence concerns the gene VEGFA and ischemia.